[Comorbidities in COPD].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archivos de Bronconeumologia

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0300-2896(10)70058-2PMID 21316557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease.

  2015cited by this paper
• Comorbidities of chronic obstructive pulmonary disease

  2011cited by this paper
• The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings

  2010cited by this paper
• EPOC y enfermedad cardiovascular

  2010cited by this paper
• Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease.

  2009cited by this paper
• [Controversies on pneumology training].

  2009cited by this paper
• Impacto de la anemia en la EPOC

  2009cited by this paper
• [Introduction. COPD].

  2009cited by this paper
• Systemic manifestations and comorbidities of COPD

  2009cited by this paper
• [Impact of anemia on COPD].

  2009cited by this paper
• [COPD and endocrine and metabolic alterations].

  2009cited by this paper
• Cardiac disease in chronic obstructive pulmonary disease.

  2008cited by this paper
• Comorbidities in chronic obstructive pulmonary disease.

  2008cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?

  2007cited by this paper
• Proyección europea de la Medicina Interna española en la base de datos PubMed (réplica)

  2007cited by this paper
• Factores pronósticos en la EPOC

  2007cited by this paper
• Factores pronsticos en la EPOC

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Statin use is associated with reduced mortality in COPD

  2006cited by this paper
• C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

  2006cited by this paper
• Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease

  2006cited by this paper
• Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?

  2006cited by this paper
• Natriuretic peptides in the diagnosis and management of heart failure

  2006cited by this paper
• Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors

  2006cited by this paper
• The natural history of chronic obstructive pulmonary disease

  2006cited by this paper
• Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

  2006cited by this paper
• Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.

  2006cited by this paper
• Brain natriuretic peptide is a prognostic parameter in chronic lung disease.

  2006cited by this paper
• Chronic disease in the elderly: back to the future of internal medicine

  2006cited by this paper
• Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study

  2006cited by this paper
• Respiratory Medications and the Risk of Cardiac Arrhythmias

  2005cited by this paper
• COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

  2005cited by this paper
• Cardiovascular morbidity and mortality in COPD.

  2005cited by this paper
• Factores determinantes de la prescripción farmacológica en los pacientes con EPOC estable. Resultados de un estudio multicéntrico español (IDENTEPOC)

  2005cited by this paper
• Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

  2005cited by this paper
• Severe pulmonary hypertension and chronic obstructive pulmonary disease.

  2005cited by this paper
• Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis

  2005cited by this paper
• Evidence supporting a new rate threshold for multifocal atrial tachycardia

  2005cited by this paper
• Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy.

  2005cited by this paper
• Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study

  2004cited by this paper
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper
• Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

  2004cited by this paper
• Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women.

  2004cited by this paper
• Inhaled and nasal corticosteroid use and the risk of fracture.

  2004cited by this paper
• Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.

  2004cited by this paper
• Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.

  2004cited by this paper
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

  2004cited by this paper
• Relevance of assessing quadriceps endurance in patients with COPD

  2004cited by this paper
• Inflammatory markers and risk of developing type 2 diabetes in women.

  2004cited by this paper
• Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2003cited by this paper
• Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

  2003cited by this paper
• Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Endocrinological disturbances in chronic obstructive pulmonary disease

  2003cited by this paper
• C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

  2003cited by this paper
• The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis

  2002cited by this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cited by this paper
• Discontinuation of furosemide decreases PaCO(2) in patients with COPD.

  2002cited by this paper
• Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease.

  2002cited by this paper
• Hospitalizations and mortality in the Lung Health Study.

  2002cited by this paper
• Pneumonic vs Nonpneumonic Acute Exacerbations of COPD

  2002cited by this paper
• Hemodynamic characterization of patients with severe emphysema.

  2002cited by this paper
• Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.

  2002cited by this paper
• Mortality after hospitalization for COPD.

  2002cited by this paper
• Hospitalizations and mortality in the Lung Health Study

  2002cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Cytokines in chronic obstructive pulmonary disease

  2001cited by this paper
• Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia

  2001cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.

  2001cited by this paper
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000cited by this paper
• Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels

  2000cited by this paper
• Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

  2000cited by this paper
• Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.

  2000cited by this paper
• The role of TNFα and TNF receptors in obesity and insulin resistance

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• The role of TNFalpha and TNF receptors in obesity and insulin resistance.

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking

  1999cited by this paper
• Bee sting dysphagia.

  1999cited by this paper
• Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

  1999cited by this paper
• Blood transfusion facilitating difficult weaning from the ventilator

  1998cited by this paper
• Multifocal atrial tachycardia.

  1998cited by this paper
• Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease.

  1998cited by this paper
• Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.

  1997cited by this paper
• Causes of death in patients with COPD and chronic respiratory failure.

  1997cited by this paper
• The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections.

  1996cited by this paper
• Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

  1996cited by this paper
• Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.

  1995cited by this paper
• Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.

  1990cited by this paper
• Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease.

  1985cited by this paper
• Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

  1981cited by this paper
• Patterns of cardiovascular dysfunction in chronic obstructive lung disease.

  1972cited by this paper

• Differences in chronic obstructive pulmonary disease among US nursing home residents with heart failure according to sex and type of heart failure

  2023cites this paper
• Prevalencia de síntomas depresivos y diagnóstico de sospecha de depresión en pacientes con EPOC

  2022cites this paper
• Descriptive Epidemiology of Chronic Obstructive Pulmonary Disease in US Nursing Home Residents with Heart Failure.

  2022cites this paper
• Supervivencia en pacientes con EPOC en tratamiento con oxigenoterapia continua domiciliaria

  2021cites this paper
• Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes

  2020cites this paper
• Influence of Pneumonia on the Survival of Patients with COPD

  2020cites this paper
• Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes

  2020cites this paper
• Differences in the Outcome of Patients with COPD according to Body Mass Index

  2020cites this paper
• Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes

  2020cites this paper
• Correlation between ventricular function as assessed by echocardiography and six-minute walk test as a surrogate of functional capacity in patients with chronic obstructive pulmonary disease

  2019cites this paper
• Readmission Due to Exacerbation of COPD: Associated Factors

  2018cites this paper
• Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study

  2016cites this paper
• Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study

  2016cites this paper
• FORMACIÓN CONTINUADA - ACTUALIZACIÓN EN MEDICINA DE FAMILIA Enfermedad pulmonar obstructiva crónica: morbimortalidad e impacto sanitario

  2016cites this paper
• Prevalence and Comorbidities of Chronic Obstructive Pulmonary Disease Among Adults in Kentucky Across Gender and Area Development Districts, 2011.

  2015cites this paper
• Enfermedad pulmonar obstructiva crónica: morbimortalidad e impacto sanitario

  2014cites this paper
• The Effect of Quitting Smoking on Costs and Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease: A Comparison of Current Smokers Versus Ex-Smokers in Routine Clinical Practice

  2014cites this paper
• Des définitions aux phénotypes de BPCO

  2014cites this paper
• [Chronic obstructive pulmonary disease: Morbimortality and healthcare burden].

  2014cites this paper
• Compromiso vertebral por osteoporosis. Un punto de vista traumatológico

  2013cites this paper
• Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.

  2013cites this paper
• Comorbidities and Health Status in Individuals With and Without COPD in Five Latin American Cities: The PLATINO Study ☆

  2013cites this paper
• Психологические расстройства у пациентов с синдромом бронхиальной обструкции

  2013cites this paper
• Comorbilidades y estado de salud en individuos con y sin EPOC en 5 ciudades de América Latina: Estudio PLATINO

  2013cites this paper
• Inflamación sistémica como nexo de unión entre la enfermedad pulmonar obstructiva crónica y sus comorbilidades

  2012cites this paper
• Prevalence of obstructive airway disease by spirometric indices in non-smoker subjects with IHD and HTN

  2012cites this paper
• [Systemic inflammation as a link between chronic obstructive pulmonary disease and its comorbidities].

  2012cites this paper
• Physical activity in chronic respiratory conditions: assessing risks for physical activity clearance and prescription.

  2012cites this paper
• Treating COPD in Chronic Patients in a Primary-Care Setting

  2011cites this paper
• [Treating COPD in chronic patients in a primary-care setting].

  2011cites this paper
• Predictors of mortality in COPD.

  2010cites this paper